The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Employment - Epic Sciences
A phase II trial in progress: Pamiparib, an investigational PARP inhibitor, in patients with metastatic castration-resistant prostate cancer and a circulating tumor cell homologous recombination deficiency (HRD) phenotype or BRCA defects.
 
Simon Chowdhury
Honoraria - Clovis Oncology; Novartis
Consulting or Advisory Role - Astellas Pharma; Bayer; Clovis Oncology; Janssen-Cilag; Pfizer
Speakers' Bureau - Pfizer
Research Funding - Sanofi/Aventis (Inst)
 
Joaquin Mateo
Consulting or Advisory Role - AstraZeneca
Speakers' Bureau - Astellas Pharma; AstraZeneca; Sanofi
Travel, Accommodations, Expenses - AstraZeneca; Ipsen; Sanofi
 
Mitchell Gross
Research Funding - Clovis Oncology; GlaxoSmithKline; Janssen
 
Andrew J. Armstrong
Honoraria - Dendreon; Janssen Oncology; Sanofi
Consulting or Advisory Role - Astellas Scientific and Medical Affairs Inc; Bayer; Dendreon; Janssen Biotech; Medivation; Novartis; Pfizer; Sanofi
Speakers' Bureau - Bayer; Dendreon; Sanofi
Research Funding - Active Biotech (Inst); Astellas Pharma (Inst); Bayer (Inst); Bristol-Myers Squibb (Inst); Dendreon (Inst); Gilead Sciences (Inst); Janssen Oncology (Inst); Medivation (Inst); Novartis (Inst); Pfizer (Inst); Roche/Genentech (Inst); Sanofi (Inst)
Patents, Royalties, Other Intellectual Property - Circulating tumor cell novel capture technology (Inst)
Travel, Accommodations, Expenses - Astellas Scientific and Medical Affairs Inc; Bayer; Dendreon; Janssen Biotech
 
Marcia Cruz-Correa
Patents, Royalties, Other Intellectual Property - Licencing agreement with Johns Hopkins University on technology.
 
Josep M. Piulats
Consulting or Advisory Role - Astellas Pharma; Bristol-Myers Squibb; Clovis Oncology; Janssen Oncology; Merck Sharp & Dohme; Roche/Genentech; VCN Biosciences
Research Funding - AstraZeneca/MedImmune; Bristol-Myers Squibb; Incyte; Janssen Oncology; Merck Sharp & Dohme; Pfizer/EMD Serono
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Janssen Oncology; Roche
 
Jean-Yves Blay
No Relationships to Disclose
 
Delcia Rivas
Employment - BeiGene
 
Luis Quintero
Employment - BeiGene
 
Henry Castro
Employment - BeiGene
 
Andong Nkobena
Employment - BeiGene
 
Mitch Raponi
Employment - BeiGene; Clovis Oncology
Stock and Other Ownership Interests - BeiGene; Clovis Oncology
 
Robert Pelham
Employment - BeiGene
 
Mark Andrew Landers
No Relationships to Disclose
 
Robert B. Montgomery
Research Funding - AstraZeneca; ESSA; Ferring; Janssen Oncology; Medivation/Astellas